Pauline Brice

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

Emmanuel Itti, Michel Meignan, Felix Reyes, 2005, Blood.

Lymphography: an old technique retains its usefulness.

Ali Guermazi, Christophe Hennequin, A. Guermazi, 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

First results of the EORTC-GELA H9 randomized trials: the H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favorable or unfavorable early stage Hodgkin’s lymphoma (HL)

E. Noordijk, M. Henry-Amar, F. Morschhauser, 2005 .

Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.

Martin Hutchings, Annibale Versari, Umberto Ricardi, 2018, Blood.

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial

Andrew Lister, Anne Sonet, Hervé Tilly, 2011, The Lancet.